Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.19.2
Consolidated Balance Sheets - USD ($)
May 31, 2019
Nov. 30, 2018
Current Assets    
Cash and cash equivalents $ 6,468,587 $ 6,040,033
Marketable securities 839,809 875,689
Accounts receivable (net of allowance for doubtful accounts of $2,432,645 and $2,264,848, respectively) 5,758,673 5,867,335
Prepaid expenses 610,581 461,815
Inventory, current portion 1,046,195 1,260,557
Other current assets 278,143 254,465
Total current assets 15,001,988 14,759,894
Property and Equipment-net 1,747,762 1,493,401
Other Assets    
Intangible assets, net 1,287,545 1,341,336
Inventory, net of current portion 12,646,000 14,775,316
Goodwill 1,941,411 1,941,411
Deferred tax assets 7,562,705 7,656,897
Deposits and other assets, net 393,974 113,888
Total other assets 24,139,635 26,136,848
Total assets 40,889,385 42,390,143
Current Liabilities    
Accounts payable 1,028,999 1,261,653
Accrued expenses 965,009 2,702,788
Current portion of note payable 3,100,000 3,100,000
Deferred revenue 8,516,593 8,365,284
Total current liabilities 13,610,601 15,429,725
Other Liabilities    
Deferred revenue, net of current portion 21,984,017 20,317,231
Contingent Consideration 3,612,048 4,282,975
Note payable, net of current portion and debt issuance costs 8,351,511 9,843,510
Long-term liability - revenue sharing agreements 1,425,000 1,425,000
Total other liabilities 35,372,576 35,868,716
Total liabilities 48,983,177 51,298,441
Commitments and contingencies (Note 10)
Stockholders' Deficit    
Preferred stock  
Common stock ($.01 par value, 20,000,000 authorized; 13,598,909 issued and 7,803,333 outstanding as of May 31, 2019 and 13,596,409 issued and 7,800,833 outstanding as of November 30, 2018) 135,989 135,964
Additional paid-in capital 35,746,866 35,515,382
Treasury stock, at cost (19,571,113) (19,571,113)
Accumulated other comprehensive income   340,984
Accumulated deficit (24,405,534) (25,329,515)
Total stockholders' deficit (8,093,792) (8,908,298)
Total liabilities and stockholders' deficit 40,889,385 42,390,143
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock  
Tianhe Stem Cell Biotechnologies Inc [Member]    
Other Assets    
Investment $ 308,000 $ 308,000